Skip to content

Avanos Medical AVNS Change in AP

Change in AP at other companies

Cardinal Health logo
Cardinal HealthCAH
$2.03B+120%
Boston Scientific logo
Boston ScientificBSX
-$512M-33.0%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
-$936K-138%
Medtronic logo
MedtronicMDT
$123M-66.4%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
-$3.83M-127%
IAR
Integra LifeSciencesIART
-$19.19M-6.6%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's change in AP?
Avanos Medical (AVNS) reported change in AP of -$2.1M in Q1 2026.
How has Avanos Medical's change in AP changed year-over-year?
Avanos Medical's change in AP increased by 67.2% year-over-year, from -$6.4M to -$2.1M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.